Sachin Shende (9 results)
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG 2013
- Softcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: New
£ 75.86
£ 3.02 shippingShips within U.S.A.Quantity: 4 available
Condition: New. pp. 120.
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 39.33
£ 60.75 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Epalrestat- An Aldose Reductase Inhibitor | A novel solution for the treatment of Diabetic Peripheral Neuropathy | Sachin Shende (u. a.) | Taschenbuch | 120 S. | Englisch | 2013 | LAP LAMBERT Academic Publishing | EAN 9783659380099 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tar…pen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
- Softcover
Seller: Mispah books, Redhill, SURRE, United KingdomMispah books
Contact seller4-star sellerCondition: Used - As new
£ 110.00
£ 25.00 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Language: English
Published by LAP LAMBERT Academic Publishing Apr 2013 2013
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
£ 44.61
£ 19.96 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -India leads the world with largest number of diabetic subjects earning the dubious distinction of being termed the diabetes capital of the world . Diabetic peripheral neuropathy developed in the majority of poorly controlled, diabet…ic patients as a late complication of diabetes. It is therefore of paramount importance to treat diabetic neuropathies appropriately as 50-60% of diabetic populations may progress to suffer from serious life threatening complications. Epalrestat is currently the only Aldose Reductase Inhibitor approved to treat subjective and objective symptoms of Diabetic Neuropathy. This book,provides how, Epalrestat 150 mg SR treatment showed clinically and statistically significant improvements in MNDS Score,Pressure threshold,and symptoms of peripheral neuropathy such as spontaneous pain,numbness in upper and lower limbs when compared with Epalrestat 50 mg IR tablet. The analysis should helps all the Medical Professionals Specially diabetologist and all diabetic patients whose need is to either prevent or treat neuropathy, a condition with pain filled life. 120 pp. Englisch.
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG 2013
- Softcover
- Print on Demand
Seller: Majestic Books, Hounslow, , United KingdomMajestic Books
Contact seller4-star sellerCondition: New
£ 76.26
£ 6.50 shippingShips from United Kingdom to U.S.A.Quantity: 4 available
Condition: New. Print on Demand pp. 120 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.
- Softcover
- Print on Demand
Seller: moluna, Greven, , Germanymoluna
Contact seller5-star sellerCondition: New
£ 40.63
£ 42.52 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Shende SachinDr. Sachin Devendrarao Shende, MBBS.MD.(Pharmacology) Govt. Medical College Aurangabad, Maharashtra., India.India leads the world with largest number of diabetic subjects earning the dubiou…s distinction of being term.
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG 2013
- Softcover
- Print on Demand
Seller: Biblios, frankfurt am main, HESSE, GermanyBiblios
Contact seller4-star sellerCondition: New
£ 79.03
£ 8.64 shippingShips from Germany to U.S.A.Quantity: 4 available
Condition: New. PRINT ON DEMAND pp. 120.
- Softcover
- Print on Demand
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 44.61
£ 52.93 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - India leads the world with largest number of diabetic subjects earning the dubious distinction of being termed the diabetes capital of the world . Diabetic peripheral neuropathy developed in the majority of poorly controlled, diabetic pa…tients as a late complication of diabetes. It is therefore of paramount importance to treat diabetic neuropathies appropriately as 50-60% of diabetic populations may progress to suffer from serious life threatening complications. Epalrestat is currently the only Aldose Reductase Inhibitor approved to treat subjective and objective symptoms of Diabetic Neuropathy. This book,provides how, Epalrestat 150 mg SR treatment showed clinically and statistically significant improvements in MNDS Score,Pressure threshold,and symptoms of peripheral neuropathy such as spontaneous pain,numbness in upper and lower limbs when compared with Epalrestat 50 mg IR tablet. The analysis should helps all the Medical Professionals Specially diabetologist and all diabetic patients whose need is to either prevent or treat neuropathy, a condition with pain filled life.
Language: English
Published by LAP LAMBERT Academic Publishing Apr 2013 2013
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
£ 49.08
£ 52.07 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -India leads the world with largest number of diabetic subjects earning the dubious distinction of being termed the 'diabetes capital of the world'. Diabetic peripheral neuropathy developed in the majority of poorly controlled, diabetic…patients as a late complication of diabetes. It is therefore of paramount importance to treat diabetic neuropathies appropriately as 50-60% of diabetic populations may progress to suffer from serious life threatening complications. Epalrestat is currently the only Aldose Reductase Inhibitor approved to treat subjective and objective symptoms of Diabetic Neuropathy. This book,provides how, Epalrestat 150 mg SR treatment showed clinically and statistically significant improvements in MNDS Score,Pressure threshold,and symptoms of peripheral neuropathy such as spontaneous pain,numbness in upper and lower limbs when compared with Epalrestat 50 mg IR tablet. The analysis should helps all the Medical Professionals Specially diabetologist and all diabetic patients whose need is to either prevent or treat neuropathy, a condition with pain filled life.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 120 pp. Englisch.
